C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
12/2002
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	DE10128331A1 New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter
12/19/2002	DE10115227A1 Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren Optical data storage medium in the information layer containing a light absorbing compound having a plurality of chromophoric centers
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002	CA2450271A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors
12/17/2002	US6495562 Such as 6-(2-(4,4-diethyl-1-isopropyl-3,4-dihydro-6-isoquinolinyl)cyclopropyl)-2 -naphthalenecarboximidamide
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/12/2002	WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	US20020188004 Heterocycle carboxamides as antiviral agents
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0782567B2 Isothiourea derivatives as no synthase inhibitors
12/11/2002	EP0752813B1 Inhibitors of metazoan parasite proteases
12/11/2002	EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/10/2002	US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
12/10/2002	US6492388 Such as n-(5-chloro-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-ethoxybenzamide
12/10/2002	US6492378 Substituted isoquinoline derivatives and their use as anticonvulsivants
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002096880A1 Novel heterocyclic compound and medicinal use thereof
12/05/2002	WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	WO2002096424A1 Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents
12/05/2002	WO2002011707A3 Drugs for incontinence
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	CA2448634A1 Novel heterocyclic compound and medicinal use thereof
12/05/2002	CA2448160A1 Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
12/03/2002	US6489479 Process for the preparation of mixed anhydrides
12/03/2002	US6489352 Antiepileptic agents; nervous system disorders
11/2002
11/28/2002	WO2002094815A1 Process for the production of quinazolines
11/28/2002	WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002	WO2002078745A3 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
11/28/2002	US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002	CA2447233A1 Process for the production of quinazolines
11/27/2002	EP1259485A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/26/2002	US6486340 Method for producing an α-aminonitrile from a tertiary anime and a cyanide through oxidation with oxygen by using a transition metal catalyst
11/26/2002	US6486175 Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
11/26/2002	US6486174 Treatment of tumor growth, metastasis, restenosis, osteoporosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, sickle cell anemia, nerve system disorders
11/26/2002	US6486173 Serotonin-7 (5-ht7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/26/2002	CA2231364C Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
11/21/2002	US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002	US20020172793 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/20/2002	CN1380288A Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482832 Heterocyclically substituted amides, their production and their use
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	US20020169326 Fatty acid derivatives
11/14/2002	US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	CA2444531A1 Isoquinolinone derivatives as parp inhibitors
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/12/2002	US6479436 Hetaroyl cyclohexanedione derivatives with herbicidal effect
11/07/2002	WO2002089128A1 An optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088088A1 Process for preparing 1-methyl-1,2,3,4-tetrahydroisoquinoline or a salt thereof
11/07/2002	WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002	US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165202 Antiinflammatory agents; antiproliferative agents
11/07/2002	US20020165201 Cyanoguanidine prodrugs
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254140A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP0901488B1 2,4-diaminopyrimidine derivatives
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/05/2002	US6476232 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same
11/05/2002	US6476047 Good bioavailability and powerful analgesic activity based on calcium channel blockade.
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
10/2002
10/31/2002	WO2002086879A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound
10/31/2002	WO2002086878A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085820A2 Chiral organic compounds and metal coordination complexes thereof
10/31/2002	US20020161236 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020161231 Intermediate for preparing camptothecin derivatives
10/31/2002	US20020161189 Used in the antagonism and agonism of delta and mu opioid receptors
10/30/2002	EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002	EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/29/2002	US6472534 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists

1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 119